发布: 2017年06月05日第7卷第11期 DOI: 10.21769/BioProtoc.2301 浏览次数: 20315
评审: Anonymous reviewer(s)
Abstract
Genome stability is continuously challenged by a wide range of DNA damaging factors. To promote a correct DNA repair and cell survival, cells orchestrate a coordinated and finely tuned cascade of events collectively known as the DNA Damage Response (DDR). Ultra Violet (UV) rays are among the main environmental sources of DNA damage and a well recognized cancer risk factor. UV rays induce the formation of toxic cyclobutane-type pyrimidine dimers (CPD) and [6-4]pyrimidine-pyrimidone (6-4PP) photoproducts which trigger the activation of the intra-S phase cell cycle checkpoint (Kaufmann, 2010) aimed at preventing replication fork collapse, late origin firing, and stabilizing fragile sites (Branzei and Foiani, 2009). To monitor the activation of the intra-S phase checkpoint in response to UV type C (UVC) exposure, the DNA fiber assay can be used to analyse the new origin firing and DNA synthesis rate (Jackson et al., 1998; Merrick et al., 2004; Alfano et al., 2016). The DNA fiber assay technique was conceived in the 90s and then further developed through the use of thymidine analogues (such as CldU and IdU), which are incorporated into the nascent DNA strands. By treating the cells in sequential mode with these analogues, which can be visualized through specific antibodies carrying different fluorophores, it is possible to monitor the replication fork activity and assess how this is influenced by UV radiations or others agents.
Keywords: Ultra Violet radiation (紫外线辐射)Background
Genomic instability is one of the hallmarks of cancer involved in both tumour development and progression (Hanahan and Weinberg, 2011). The preservation of genomic stability depends on a complex cascade of finely tuned events which are collectively known as the DNA damage response. This includes the activation of cell cycle checkpoints, which stall cell cycle to allow the cellular repair machinery to mend the damage. The identification of novel druggable proteins, involved in the DNA repair mechanisms, is part of modern cancer therapy. In this context, the DNA fiber assay can be used as a readout of replication fork activity to identify new potential players in the regulation of the intra-S phase checkpoint, which is triggered upon exposure to various chemotherapeutic drugs.
The unique chemistry of DNA, of its constituents and its chemical-physical properties allowed pioneering scientists to visualize the whole length of DNA fibers, first by labelling DNA with tritiated thymidine followed by detection through autoradiography (Cairns, 1963). Then Bensimon and colleagues showed that it was possible to align and ‘comb’ the DNA fibers on a solid matrix achieving a uniform stretching and an easy access for specific hybridizations (Bensimon et al., 1994). Jackson and Pombo were the first to use sequential labelling with halogenated pyrimidines, such as bromo-deoxyuridine (BrdU) and iodo-deoxyuridine (IdU), which are incorporated into DNA as thymidine analogues (Jackson and Pombo, 1998). This allowed them to assess qualitatively and quantitatively the activity of replicon clusters in HeLa cells at different times during S phase. Afterwards another study (Merrick et al., 2004) described a modified DNA fiber labelling, which was adapted by a classical DNA fiber autoradiography (Huberman and Riggs, 1968). Diffley and colleagues used pulse labelling with two halogenated nucleotides: chloro-deoxyuridine (CldU) and IdU, which could be differentially detected through specific antibodies, each carrying a different fluorescent dye. This allowed to visualize through fluorescent microscopy the effect of a specific cell treatment on the dynamics of the DNA synthesis process. The protocol described below was made as described by the two previously cited protocols with some modifications (Jackson and Pombo, 1998; Merrick et al., 2004).
Materials and Reagents
Equipment
Software
Procedure
文章信息
版权信息
© 2017 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Luigi, A., Giordano, A. and Pentimalli, F. (2017). DNA Fiber Assay upon Treatment with Ultraviolet Radiations. Bio-protocol 7(11): e2301. DOI: 10.21769/BioProtoc.2301.
分类
癌症生物学 > 基因组不稳定性及突变 > 细胞生物学试验
生物化学 > DNA > 单分子活性
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link